0      0


030 - Pharmacology Workshop: Part 1 - Psychiatric Medication Update & Part 2 - New Treatments for COVID-19


‐ Sep 14, 2022 4:00pm


Credits: None available.

This workshop addresses current treatment protocols for mental health disorders and COVID-19 in the older adult population. Discussion includes available and effective treatment options, the mechanism of action, potential advantages and disadvantages to treatment protocols, and application of pharmacological principles into clinical decision-making.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 9/17/2024.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your nursing continuing professional development (NCPD) certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):

Planning Committee Disclosures:

There are no disclosures to declare.

Speaker Disclosures:
There are no disclosures to declare.

Commercial Support:
No commercial support declared.

Accreditation Statement:
This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).

Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5387.

Learning Outcome:
After completing this learning activity, the participant will be able to identify available and effective treatment options and apply pharmacological principles into clinical decision-making.


Credits Available


Pharmacology Workshop: Part 1 - Psychiatric Medication Update & Part 2 - New Treatments for COVID-19